Clinical Trial Update: A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of HST101 in Chinese patients with hypercholesterolemia and related dyslipidemias; the trial is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Dyslipidemia
• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• HST101

Snippet

Sponsor: Hasten Biopharmaceutical Co., Ltd. | Conditions: Hypercholesterolemia, Dyslipidemias | Phase 3 | Status: RECRUITING